Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
1D), indicating that the brain atrophy in GCLC-KO was associated with neuronal loss
some research schedules extend to ~16 weeks
There is no approved dosing regimen for routine clinical use
Peptides in pre-mixed aqueous solution begin degrading from the moment of reconstitution, with the rate depending on pH, temperature, and the specific peptide sequence
J Neurosci 34(15):53225334 Holst JJ (2007) The physiology of glucagon-like peptide 1
In addition, antibodies targeting CD209, lymphocyte antigen 75 (LY75, also known as DEC-205), or CLEC9A can be utilized to transport antigens to DCs for cross-presentation
US$ 21.34
US$ 26.83
US$ 20.74
